138 related articles for article (PubMed ID: 21216233)
1. Mutational analysis of G-protein coupled receptor--FFA2.
Swaminath G; Jaeckel P; Guo Q; Cardozo M; Weiszmann J; Lindberg R; Wang Y; Schwandner R; Li Y
Biochem Biophys Res Commun; 2011 Feb; 405(1):122-7. PubMed ID: 21216233
[TBL] [Abstract][Full Text] [Related]
2. Identification and functional characterization of allosteric agonists for the G protein-coupled receptor FFA2.
Lee T; Schwandner R; Swaminath G; Weiszmann J; Cardozo M; Greenberg J; Jaeckel P; Ge H; Wang Y; Jiao X; Liu J; Kayser F; Tian H; Li Y
Mol Pharmacol; 2008 Dec; 74(6):1599-609. PubMed ID: 18818303
[TBL] [Abstract][Full Text] [Related]
3. Selective orthosteric free fatty acid receptor 2 (FFA2) agonists: identification of the structural and chemical requirements for selective activation of FFA2 versus FFA3.
Schmidt J; Smith NJ; Christiansen E; Tikhonova IG; Grundmann M; Hudson BD; Ward RJ; Drewke C; Milligan G; Kostenis E; Ulven T
J Biol Chem; 2011 Mar; 286(12):10628-40. PubMed ID: 21220428
[TBL] [Abstract][Full Text] [Related]
4. Defining the molecular basis for the first potent and selective orthosteric agonists of the FFA2 free fatty acid receptor.
Hudson BD; Due-Hansen ME; Christiansen E; Hansen AM; Mackenzie AE; Murdoch H; Pandey SK; Ward RJ; Marquez R; Tikhonova IG; Ulven T; Milligan G
J Biol Chem; 2013 Jun; 288(24):17296-312. PubMed ID: 23589301
[TBL] [Abstract][Full Text] [Related]
5. Agonism and allosterism: the pharmacology of the free fatty acid receptors FFA2 and FFA3.
Milligan G; Stoddart LA; Smith NJ
Br J Pharmacol; 2009 Sep; 158(1):146-53. PubMed ID: 19719777
[TBL] [Abstract][Full Text] [Related]
6. The first synthetic agonists of FFA2: Discovery and SAR of phenylacetamides as allosteric modulators.
Wang Y; Jiao X; Kayser F; Liu J; Wang Z; Wanska M; Greenberg J; Weiszmann J; Ge H; Tian H; Wong S; Schwandner R; Lee T; Li Y
Bioorg Med Chem Lett; 2010 Jan; 20(2):493-8. PubMed ID: 20005104
[TBL] [Abstract][Full Text] [Related]
7. Allosteric rescuing of loss-of-function FFAR2 mutations.
Swaminath G; Jaeckel P; Guo Q; Cardozo M; Weiszmann J; Lindberg R; Wang Y; Schwandner R; Li Y
FEBS Lett; 2010 Oct; 584(19):4208-14. PubMed ID: 20837008
[TBL] [Abstract][Full Text] [Related]
8. Extracellular loop 2 of the free fatty acid receptor 2 mediates allosterism of a phenylacetamide ago-allosteric modulator.
Smith NJ; Ward RJ; Stoddart LA; Hudson BD; Kostenis E; Ulven T; Morris JC; Tränkle C; Tikhonova IG; Adams DR; Milligan G
Mol Pharmacol; 2011 Jul; 80(1):163-73. PubMed ID: 21498659
[TBL] [Abstract][Full Text] [Related]
9. Ligands at the Free Fatty Acid Receptors 2/3 (GPR43/GPR41).
Milligan G; Bolognini D; Sergeev E
Handb Exp Pharmacol; 2017; 236():17-32. PubMed ID: 27757758
[TBL] [Abstract][Full Text] [Related]
10. Non-equivalence of Key Positively Charged Residues of the Free Fatty Acid 2 Receptor in the Recognition and Function of Agonist Versus Antagonist Ligands.
Sergeev E; Hansen AH; Pandey SK; MacKenzie AE; Hudson BD; Ulven T; Milligan G
J Biol Chem; 2016 Jan; 291(1):303-17. PubMed ID: 26518871
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, Activity, and Docking Study of Novel Phenylthiazole-Carboxamido Acid Derivatives as FFA2 Agonists.
Ma L; Wang T; Shi M; Fu P; Pei H; Ye H
Chem Biol Drug Des; 2016 Jul; 88(1):26-37. PubMed ID: 26808470
[TBL] [Abstract][Full Text] [Related]
12. A Novel Allosteric Activator of Free Fatty Acid 2 Receptor Displays Unique Gi-functional Bias.
Bolognini D; Moss CE; Nilsson K; Petersson AU; Donnelly I; Sergeev E; König GM; Kostenis E; Kurowska-Stolarska M; Miller A; Dekker N; Tobin AB; Milligan G
J Biol Chem; 2016 Sep; 291(36):18915-31. PubMed ID: 27385588
[TBL] [Abstract][Full Text] [Related]
13. Chemically engineering ligand selectivity at the free fatty acid receptor 2 based on pharmacological variation between species orthologs.
Hudson BD; Christiansen E; Tikhonova IG; Grundmann M; Kostenis E; Adams DR; Ulven T; Milligan G
FASEB J; 2012 Dec; 26(12):4951-65. PubMed ID: 22919070
[TBL] [Abstract][Full Text] [Related]
14. Allosteric targeting of the FFA2 receptor (GPR43) restores responsiveness of desensitized human neutrophils.
Frei R; Nordlohne J; Hüser U; Hild S; Schmidt J; Eitner F; Grundmann M
J Leukoc Biol; 2021 Apr; 109(4):741-751. PubMed ID: 32803826
[TBL] [Abstract][Full Text] [Related]
15. Extracellular ionic locks determine variation in constitutive activity and ligand potency between species orthologs of the free fatty acid receptors FFA2 and FFA3.
Hudson BD; Tikhonova IG; Pandey SK; Ulven T; Milligan G
J Biol Chem; 2012 Nov; 287(49):41195-209. PubMed ID: 23066016
[TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of the free fatty acid receptor 2 (FFA2) and a novel functional FFA2-like receptor (FFA2L) for short-chain fatty acids in pigs: evidence for the existence of a duplicated FFA2 gene (FFA2L) in some mammalian species.
Zhang J; Cheng S; Wang Y; Yu X; Li J
Domest Anim Endocrinol; 2014 Apr; 47():108-18.e1. PubMed ID: 24315753
[TBL] [Abstract][Full Text] [Related]
17. Conserved polar residues in transmembrane domains V, VI, and VII of free fatty acid receptor 2 and free fatty acid receptor 3 are required for the binding and function of short chain fatty acids.
Stoddart LA; Smith NJ; Jenkins L; Brown AJ; Milligan G
J Biol Chem; 2008 Nov; 283(47):32913-24. PubMed ID: 18801738
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological properties of acid N-thiazolylamide FFA2 agonists.
Brown AJ; Tsoulou C; Ward E; Gower E; Bhudia N; Chowdhury F; Dean TW; Faucher N; Gangar A; Dowell SJ
Pharmacol Res Perspect; 2015 Jun; 3(3):e00141. PubMed ID: 26236484
[TBL] [Abstract][Full Text] [Related]
19. FFA2 and FFA3 in Metabolic Regulation.
Tang C; Offermanns S
Handb Exp Pharmacol; 2017; 236():205-220. PubMed ID: 27757760
[TBL] [Abstract][Full Text] [Related]
20. FFA2-, but not FFA3-agonists inhibit GSIS of human pseudoislets: a comparative study with mouse islets and rat INS-1E cells.
Lorza-Gil E; Kaiser G; Rexen Ulven E; König GM; Gerst F; Oquendo MB; Birkenfeld AL; Häring HU; Kostenis E; Ulven T; Ullrich S
Sci Rep; 2020 Oct; 10(1):16497. PubMed ID: 33020504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
